Home >> Tag Archives: Diasorin Molecular—

Tag Archives: Diasorin Molecular—

DiaSorin gets FDA OK for extended swab samples

June 27, 2018—DiaSorin Molecular received FDA clearance extending the sample type claims of its Simplexa HSV 1 & 2 Direct assay. The clearance expands the type of samples that can be tested, from genital swabs to all cutaneous and mucocutaneous swab samples. The Simplexa HSV 1 & 2 Direct kit real-time PCR assay, for use on DiaSorin’s Liaison MDX instrument, ...

Read More »